• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗组胺药富马酸依美斯汀的肝脏转运:大鼠和豚鼠种间差异

Hepatic transport of an antiallergic agent, emedastine difumarate: interspecies difference in rats and guinea pigs.

作者信息

Sakai T, Awata N, Watanabe J

机构信息

Pharmaceuticals Research Center, Kanebo, Ltd., Osaka, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1990 May;38(5):1349-52. doi: 10.1248/cpb.38.1349.

DOI:10.1248/cpb.38.1349
PMID:2393961
Abstract

Interspecies differences in the hepatic transport of an antiallergic agent, emedastine difumarate (KG-2413), were investigated in rats and guinea pigs, taking notice of the influx, efflux and metabolic processes. When the concentration of emedastine in the injection was varied from 2 microM to 10 mM, the extraction ratio of total radioactive compound to the liver at 18 s in rats and 25 s in guinea pigs after the rapid portal injection was more than 90% of the dose. This suggested that the influx velocity of emedastine into the liver was extremely fast, and that there was no interspecies difference in the influx process. The disappearance of unchanged emedastine from the liver was described by biexponential curve in rats and monoexponential curve in guinea pigs after rapid portal injection of 100 microM solution. This difference might be related to the interspecies difference in the binding of emedastine to the liver tissue. The time courses of disappearance of total radioactive compound and unchanged emedastine from the liver were analyzed using a compartment model for the examination of the efflux and metabolic processes. Emedastine was observed to have a pronounced interspecies difference in metabolic rate constant, but there was no pronounced interspecies difference in its efflux rate constant.

摘要

以抗组胺药富马酸依美斯汀(KG-2413)为研究对象,通过关注其流入、流出及代谢过程,对大鼠和豚鼠肝脏转运的种间差异进行了研究。快速门静脉注射时,当依美斯汀注射浓度在2 microM至10 mM之间变化时,大鼠在注射后18秒、豚鼠在注射后25秒时,肝脏对总放射性化合物的摄取率超过给药剂量的90%。这表明依美斯汀流入肝脏的速度极快,且在流入过程中不存在种间差异。快速门静脉注射100 microM溶液后,大鼠肝脏中未变化的依美斯汀的消失情况呈双指数曲线,而豚鼠则呈单指数曲线。这种差异可能与依美斯汀与肝脏组织结合的种间差异有关。使用房室模型分析了肝脏中总放射性化合物和未变化的依美斯汀消失的时间过程,以考察流出和代谢过程。结果发现,依美斯汀的代谢速率常数存在明显的种间差异,但其流出速率常数不存在明显的种间差异。

相似文献

1
Hepatic transport of an antiallergic agent, emedastine difumarate: interspecies difference in rats and guinea pigs.抗组胺药富马酸依美斯汀的肝脏转运:大鼠和豚鼠种间差异
Chem Pharm Bull (Tokyo). 1990 May;38(5):1349-52. doi: 10.1248/cpb.38.1349.
2
[In vitro metabolism of an antiallergic agent, emedastine difumarate, in rats and guinea pigs].[抗组胺药富马酸依美斯汀在大鼠和豚鼠体内的体外代谢]
Yakugaku Zasshi. 1990 Jan;110(1):40-8. doi: 10.1248/yakushi1947.110.1_40.
3
Interspecies differences in pharmacokinetics of an antiallergic agent, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1,4-diazepin-1-yl) benzimidazole difumarate (KG-2413) after intravenous administration to rats, guinea pigs and dogs.
Chem Pharm Bull (Tokyo). 1989 Mar;37(3):753-6. doi: 10.1248/cpb.37.753.
4
Pharmacokinetics of an antiallergic agent, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1, 4-diazepin-1-yl)-1H-benzimidazole difumarate (KG-2413) after oral administration: interspecies differences in rats, guinea pigs and dogs.
J Pharmacobiodyn. 1989 Sep;12(9):530-6. doi: 10.1248/bpb1978.12.530.
5
[Selective and sensitive determination of an antiallergic agent, emedastine difumarate (KG-2413), in human plasma by the radioreceptor assay combined with a high-performance liquid chromatography].[采用放射受体分析法结合高效液相色谱法对人血浆中抗组胺药富马酸依美斯汀(KG-2413)进行选择性和灵敏测定]
Yakugaku Zasshi. 1989 Oct;109(10):749-54. doi: 10.1248/yakushi1947.109.10_749.
6
Inhibitory effects of emedastine difumarate on histamine release.
Jpn J Pharmacol. 1993 Jun;62(2):137-43. doi: 10.1254/jjp.62.137.
7
Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.新型抗组胺药富马酸依美斯汀在肾功能不全患者中的药代动力学
Eur J Clin Pharmacol. 2001 Mar;56(12):905-10. doi: 10.1007/s002280000256.
8
Transdermal administration of emedastine.依美斯汀的透皮给药。
Biol Pharm Bull. 1993 Sep;16(9):884-8. doi: 10.1248/bpb.16.884.
9
Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers.健康志愿者中未标记和(14)C标记的富马酸依美斯汀的药代动力学和质量平衡研究。
Xenobiotica. 2002 Sep;32(9):761-70. doi: 10.1080/00498250210143001.
10
Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.富马酸依美斯汀:对其在过敏性疾病中组织重塑潜在改善作用的综述
Expert Opin Pharmacother. 2009 Aug;10(11):1859-67. doi: 10.1517/14656560903078410.